Ci Private Wealth, LLC Biomarin Pharmaceutical Inc Transaction History

Ci Private Wealth, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$74.43 - $92.22 $23,966 - $29,694	-322 Reduced 6.99%	4,286 $352,000
Q1 2024 May 09, 2024	BUY	$83.81 - $99.0 $9,135 - $10,791	109 Added 2.42%	4,608 $402,000
Q4 2023 Feb 09, 2024	BUY	$76.22 - $98.51 $32,698 - $42,260	429 Added 10.54%	4,499 $433,000
Q3 2023 Nov 03, 2023	SELL	$85.07 - $94.48 $2,467 - $2,739	-29 Reduced 0.71%	4,070 $360,000
Q2 2023 Aug 10, 2023	BUY	$86.68 - $100.3 $14,908 - $17,251	172 Added 4.38%	4,099 $355,000
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $2,456 - $3,283	-28 Reduced 0.71%	3,927 $381,000
Q4 2022 Feb 15, 2023	BUY	$80.93 - $108.63 $320,078 - $429,631	3,955 New	3,955 $409,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Ci Private Wealth, LLC with notifications on news.